Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2026)

Maravai Lifesciences Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• In Q1 2026, Inventory Average fell 18.93% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 18.93% YoY), while the FY2025 annual figure was $45.3 million, down 10.74% from the prior year.
• Inventory Average was $40.5 million for Q1 2026 at Maravai Lifesciences Holdings, down from $42.9 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $61.3 million in Q3 2022 to a low of $40.5 million in Q1 2026.
• Historically, Inventory Average has averaged $49.9 million across 5 years, with a median of $49.9 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory Average gained 28.02% in 2022, then declined 21.21% in 2023.
• A 5-year view of Inventory Average shows it stood at $52.8 million in 2022, then decreased by 4.77% to $50.3 million in 2023, then rose by 0.08% to $50.3 million in 2024, then dropped by 14.7% to $42.9 million in 2025, then dropped by 5.67% to $40.5 million in 2026.
• The last three Inventory Average figures came in at $40.5 million (Q1 2026), $42.9 million (Q4 2025), and $46.0 million (Q3 2025), per Business Quant data.